Tagged with P

Pharma Legal Handbook Preclinical & clinical trial requirements in Spain – a comprehensive legal overview. Prepared in association with Faus Moliner Abogados, a leading law firm in Spain, this is an extract from The Pharma Legal Handbook: Spain, available to purchase here for GBP 119.   1. Are clinical trials required to be…

Global Thomas Schinecker is set to replace long-standing CEO, Severin Schwan, in the leadership shakeup Roche announced a few months ago. Schinecker is known for leading the company’s COVID-19 test kit efforts as the CEO of its diagnostics division, but he comes to the helm after an almost 20-year career at…

Pharma Legal Handbook Key legal info on regulatory, pricing and reimbursement in Spain. Prepared in association with Faus Moliner Abogados, a leading law firm in Spain, this is an extract from The Pharma Legal Handbook: Spain.   The guide is available to purchase here for GBP 119.   1. What are the regulatory…

Latvia Latvia has seen some major breakthroughs in recent years: more innovative medicines are available to patients than ever before; the market for commercial, OTC and reimbursable medicinal products has achieved new heights, and we are in a strong position to continue this trend. What has been accomplished and what challenges…

Egypt Sherif Amin, an 18-year industry veteran with 12 years of experience in oncology leadership roles across MEA, is the recipient of several awards, including the 2019 Oncology President Award, 2015 CEO Innovation Award, and 2014 MENA Leadership Award. A recent appointee as country president for Novartis Egypt, Amin describes how…

Singapore MSD is set to inject an additional USD 500 million into its existing Singapore manufacturing operations with two new facilities to produce vaccines and biologics. One of the new plants will turn out MSD’s immunotherapy for cancer and its human papillomavirus (HPV) vaccine for the Asia-Pacific region. The reason we…

Greece A pharma market snapshot of Greece, a country whose life expectancy ranks well above the European Union member states’ average. Greece also boasts a relatively high pharmaceutical expenditure compared to its European neighbors and has seen pharmaceutical sales, led by exports, grow exponentially in recent years.   Total Pharmaceutical Expenditure…

Pharma Legal Handbook Key legal info on biosimilars & biologics in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in Switzerland, this is an extract from The Pharma Legal Handbook: Switzerland, available to purchase here for GBP 119. 1. Are biosimilar medicines considered the same as generic medicines in…

Pharma Legal Handbook Key legal info on localization in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in Switzerland, this is an extract from The Pharma Legal Handbook: Switzerland, available to purchase here for GBP 119. 1. Are there any rules or regulations requiring and/or encouraging localization in your…

Pharma Legal Handbook Key legal info on orphan drugs & rare diseases in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in Switzerland, this is an extract from The Pharma Legal Handbook: Switzerland, available to purchase here for GBP 119. 1. What is the definition of Rare Diseases in…

Pharma Legal Handbook Key legal info on cannabinoids in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in Switzerland, this is an extract from The Pharma Legal Handbook: Switzerland, available to purchase here for GBP 119.   Cannabinoid Drugs 1. Are Cannabinoid Drugs authorized in your country? In principle,…

Pharma Legal Handbook Key legal info on regulatory reforms in Swiss Pharma. Prepared in association with Wenger Plattner, a leading law firm in Switzerland, this is an extract from The Pharma Legal Handbook: Switzerland, available to purchase here for GBP 119.   1. Are there proposals for reform or significant change to the…